相似文献
1
EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin.
Mol Cell. 2009 Nov 25;36(4):547-59. doi: 10.1016/j.molcel.2009.09.034.
2
EGFR phosphorylates FAM129B to promote Ras activation.
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):644-9. doi: 10.1073/pnas.1517112113. Epub 2015 Dec 31.
3
Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity.
J Biol Chem. 2007 Apr 13;282(15):11221-9. doi: 10.1074/jbc.M611871200. Epub 2007 Feb 7.
4
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.
Nature. 2011 Dec 1;480(7375):118-22. doi: 10.1038/nature10598.
5
CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival.
Mol Cell Biochem. 2011 Oct;356(1-2):127-32. doi: 10.1007/s11010-011-0965-4. Epub 2011 Jul 7.
6
Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of β-catenin transcriptional activity.
J Cell Physiol. 2011 Jul;226(7):1953-9. doi: 10.1002/jcp.22527.
7
α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivation.
J Neurooncol. 2011 Jul;103(3):445-51. doi: 10.1007/s11060-010-0413-4. Epub 2010 Sep 26.
8
Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.
Oncogene. 2015 Jul;34(28):3688-99. doi: 10.1038/onc.2014.299. Epub 2014 Sep 22.
9
CK2 controls the recruitment of Wnt regulators to target genes in vivo.
Curr Biol. 2006 Nov 21;16(22):2239-44. doi: 10.1016/j.cub.2006.09.034.
10
PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis.
Nat Commun. 2016 Aug 3;7:12431. doi: 10.1038/ncomms12431.
引用本文的文献
1
Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth.
Nat Commun. 2025 Aug 4;16(1):7156. doi: 10.1038/s41467-025-62566-4.
2
CLOCK promotes proliferation of glioblastoma cells through acetylating PRPS1/2.
J Neurooncol. 2025 Jul 19. doi: 10.1007/s11060-025-05163-1.
3
CK2 in the spotlight: decoding its role in hematological malignancies and therapeutic applications.
Discov Oncol. 2025 May 30;16(1):965. doi: 10.1007/s12672-025-02797-5.
4
Sanqi oral solution alleviates podocyte apoptosis in experimental membranous nephropathy by mediating EMT through the ERK/CK2-α/β-catenin pathway.
Front Pharmacol. 2025 May 9;16:1503961. doi: 10.3389/fphar.2025.1503961. eCollection 2025.
5
Tumor heterogeneity and resistance in glioblastoma: the role of stem cells.
Apoptosis. 2025 May 15. doi: 10.1007/s10495-025-02123-y.
6
p53 inhibits OTUD5 transcription to promote GPX4 degradation and induce ferroptosis in gastric cancer.
Clin Transl Med. 2025 Mar;15(3):e70271. doi: 10.1002/ctm2.70271.
7
Phospholipase C Beta 2 as a Key Regulator of Tumor Progression and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Renal Cell Carcinoma.
Biomedicines. 2025 Jan 26;13(2):304. doi: 10.3390/biomedicines13020304.
8
Genetically encoded biosensor for fluorescence lifetime imaging of PTEN dynamics in the intact brain.
Nat Methods. 2025 Apr;22(4):764-777. doi: 10.1038/s41592-025-02610-9. Epub 2025 Feb 20.
9
Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma.
Cancers (Basel). 2025 Feb 4;17(3):520. doi: 10.3390/cancers17030520.
10
EGFR and EGFRvIII coopt host defense pathways promoting progression in glioblastoma.
Neuro Oncol. 2025 Feb 10;27(2):383-397. doi: 10.1093/neuonc/noae182.
本文引用的文献
1
Wnt/beta-catenin signaling: new (and old) players and new insights.
Curr Opin Cell Biol. 2008 Apr;20(2):119-25. doi: 10.1016/j.ceb.2008.01.009. Epub 2008 Mar 12.
2
Malignant astrocytic glioma: genetics, biology, and paths to treatment.
Genes Dev. 2007 Nov 1;21(21):2683-710. doi: 10.1101/gad.1596707.
3
Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.
Semin Cancer Biol. 2008 Feb;18(1):53-64. doi: 10.1016/j.semcancer.2007.08.003. Epub 2007 Sep 4.
4
Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity.
J Biol Chem. 2007 Apr 13;282(15):11221-9. doi: 10.1074/jbc.M611871200. Epub 2007 Feb 7.
5
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma.
Nat Med. 2007 Jan;13(1):84-8. doi: 10.1038/nm1517. Epub 2006 Dec 10.
6
CK2 controls the recruitment of Wnt regulators to target genes in vivo.
Curr Biol. 2006 Nov 21;16(22):2239-44. doi: 10.1016/j.cub.2006.09.034.
7
ERK1/2 MAP kinases in cell survival and apoptosis.
IUBMB Life. 2006 Nov;58(11):621-31. doi: 10.1080/15216540600957438.
8
Catenins: keeping cells from getting their signals crossed.
Dev Cell. 2006 Nov;11(5):601-12. doi: 10.1016/j.devcel.2006.10.010.
9
Wnt/beta-catenin signaling in development and disease.
Cell. 2006 Nov 3;127(3):469-80. doi: 10.1016/j.cell.2006.10.018.
10
The epidermal growth factor receptor pathway: a model for targeted therapy.
Clin Cancer Res. 2006 Sep 15;12(18):5268-72. doi: 10.1158/1078-0432.CCR-05-1554.
Zotero 插件